|
1
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Greenwald I: LIN-12/Notch signaling:
lessons from worms and flies. Genes Dev. 12:1751–1762. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mumm JS and Kopan R: Notch signaling: from
the outside in. Dev Biol. 228:151–165. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jarriault S, Le Bail O, Hirsinger E, et
al: Delta-1 activation of Notch-1 signaling results in HES-1
transactivation. Mol Cell Biol. 18:7423–7431. 1998.PubMed/NCBI
|
|
5
|
Kuroda K, Tani S, Tamura K, et al:
Delta-induced Notch signaling mediated by RBP-J inhibits MyoD
expression and myogenesis. J Biol Chem. 274:7238–7244. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohishi K, Katayama N, Shiku H, et al:
Notch signaling in hematopoiesis. Cell Dev Bio1. 4:143–150.
2003.
|
|
7
|
Leong KG and Karsan A: Recent insights
into the role of Notch signaling in tumorigenesis. Blood.
107:2223–2233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pancewicz J, Taylor JM, Datta A, et al:
Notch signaling contributes to proliferation and tumor formation of
human T-cell leukemia virus type 1-associated adult T- cell
leukemia. Proc Natl Acad Sci USA. 107:16619–16624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Pooter RF, Schmitt TM, de la Pompa JL,
et al: Notch signaling requires GATA-2 to inhibit myelopoiesis from
embryonic stem cells and primary hemopoietic progenitors. J
Immunol. 176:5267–5275. 2006.PubMed/NCBI
|
|
10
|
Ishiko E, Matsumura I, Ezoe S, et al:
Notch signals inhibit the development of erythroid/megakaryocytic
cells by suppressing GATA-1 activity through the induction of HES1.
J Biol Chem. 280:4929–4939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin DD, Fan FY, Hu XB, et al: Notch
signaling inhibits the growth of the human chronic myeloid leukemia
cell line K562. Leuk Res. 33:109–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zweidler-McKay PA, He Y, Xu L, et al:
Notch signaling is a potent inducer of growth arrest and apoptosis
in a wide range of B-cell malignancies. Blood. 106:3898–3906. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen W, Jiang H, Wang M, et al: Effects of
chlorpyrifos exposure on kidney Notch2-Jagged1 pathway of early
prenatal embryo. Birth Defects Res B Dev Reprod Toxicol. 92:97–101.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bastide K, Uqolin N, Levalois C, et al:
Are adenosquamous lung carcinomas a simple mix of adenocarcinomas
and squamous cell carcinomas, or more complex at the molecular
level? Lung Cancer. 68:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gibb DR, EI Shikh M, Kang DJ, et al:
ADAM10 is essential for Notch2-dependent marginal zone B cell
development and CD23 cleavage in vivo. J Exp Med. 207:623–635.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mazur PK, Grüner BM, Nakhai H, et al:
Identification of epidermal Pdx1 expression discloses different
roles of Notch1 and Notch2 in murine Kras(G12D)-indenced skin
carcinogenesis in vivo. PloS one. 5:e135782010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang PM, Huang WC, Lin YC, et al: Loss of
IKKbeta activity increases p53 stability and p21 expression leading
to cell cycle arrest and apoptosis. J Cell Mol Med. 14:687–698.
2010.PubMed/NCBI
|
|
18
|
Cheng X, Huber TL, Chen VC, et al: Numb
mediates the interaction between Wnt and Notch to modulate
primitive erythropoietic specification from the hemangioblast.
Development. 135:3447–3458. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Banerjee S, Ahmad A, et al:
Activated K-ras and INK4a/Arf deficiency cooperate during the
development of pancreatic cancer by activation of Notch and NF-κB
signaling pathways. PloS One. 6:e205372011.PubMed/NCBI
|
|
20
|
Song LL, Peng Y, Yun J, et al: Notch-1
associates with IKKalpha and regulates IKK activity in cervical
cancer cells. Oncogene. 27:5833–5844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frenzel A, Grespi F, Chmelewskij W, et al:
Bcl2 family proteins in carcinogenesis and the treatment of cancer.
Apoptosis. 14:584–596. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morita Y, Ismail DM, Elkon KB, et al:
Dichotomous response to transforming growth factor β after T cell
receptor activation by naive CD4+ T cells from DBA/1 mice: enhanced
retinoic acid receptor-related orphan nuclear receptor γt
expression yet reduced FoxP3 expression. Arthritis Rheum.
63:118–126. 2011.
|
|
23
|
Rorke EA, Zhang D, Choo CK, et al:
TGF-beta-mediated cell cycle arrest of HPV16-immortalized human
ectocervical cells correlates with decreased E6/E7 mRNA and
increased p53 and p21(WAF-1) expression. Exp Cell Res. 259:149–157.
2000. View Article : Google Scholar : PubMed/NCBI
|
